ATP6V1D Human 1,2-dimethylhydrazine multiple interactions ISO Atp6v1d (Mus musculus) 6480464 [1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ATP6V1D mRNA CTD PMID:22206623 ATP6V1D Human 1-naphthyl isothiocyanate increases expression ISO Atp6v1d (Rattus norvegicus) 6480464 1-Naphthylisothiocyanate results in increased expression of ATP6V1D mRNA CTD PMID:25380136 ATP6V1D Human 1-nitropropane increases expression ISO Atp6v1d (Rattus norvegicus) 6480464 1-nitropropane results in increased expression of ATP6V1D mRNA CTD PMID:17070881 ATP6V1D Human 17alpha-ethynylestradiol increases expression ISO Atp6v1d (Mus musculus) 6480464 Ethinyl Estradiol results in increased expression of ATP6V1D mRNA CTD PMID:17942748 ATP6V1D Human 17alpha-ethynylestradiol multiple interactions ISO Atp6v1d (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ATP6V1D mRNA CTD PMID:17942748 ATP6V1D Human 17alpha-ethynylestradiol affects expression ISO Atp6v1d (Mus musculus) 6480464 Ethinyl Estradiol affects the expression of ATP6V1D mRNA CTD PMID:17555576 ATP6V1D Human 17beta-estradiol decreases expression ISO Atp6v1d (Mus musculus) 6480464 Estradiol results in decreased expression of ATP6V1D mRNA CTD PMID:39298647 ATP6V1D Human 2,2',4,4'-Tetrabromodiphenyl ether multiple interactions ISO Atp6v1d (Mus musculus) 6480464 [Flame Retardants results in increased abundance of 2,2',4,4'-tetrabromodiphenyl ether] which results in increased expression of more ... CTD PMID:38995820 ATP6V1D Human 2,2',4,4'-Tetrabromodiphenyl ether decreases expression EXP 6480464 2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of ATP6V1D protein CTD PMID:31675489 ATP6V1D Human 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Atp6v1d (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ATP6V1D mRNA CTD PMID:17942748 ATP6V1D Human 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Atp6v1d (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of ATP6V1D mRNA CTD PMID:21570461 ATP6V1D Human 2,4-diaminotoluene increases expression ISO Atp6v1d (Rattus norvegicus) 6480464 2,4-diaminotoluene results in increased expression of ATP6V1D mRNA CTD PMID:17070881 ATP6V1D Human 2,4-dinitrotoluene affects expression ISO Atp6v1d (Rattus norvegicus) 6480464 2,4-dinitrotoluene affects the expression of ATP6V1D mRNA CTD PMID:21346803 ATP6V1D Human 2,6-diaminotoluene increases expression ISO Atp6v1d (Rattus norvegicus) 6480464 2,6-diaminotoluene results in increased expression of ATP6V1D mRNA CTD PMID:17070881 ATP6V1D Human 2,6-dinitrotoluene affects expression ISO Atp6v1d (Rattus norvegicus) 6480464 2,6-dinitrotoluene affects the expression of ATP6V1D mRNA CTD PMID:21346803 ATP6V1D Human 2-acetamidofluorene increases expression ISO Atp6v1d (Rattus norvegicus) 6480464 2-Acetylaminofluorene results in increased expression of ATP6V1D mRNA CTD PMID:17070881 ATP6V1D Human 2-hydroxypropanoic acid decreases expression EXP 6480464 Lactic Acid results in decreased expression of ATP6V1D mRNA CTD PMID:30851411 ATP6V1D Human 2-methylcholine affects expression EXP 6480464 beta-methylcholine affects the expression of ATP6V1D mRNA CTD PMID:21179406 ATP6V1D Human 2-nitro-p-phenylenediamine increases expression ISO Atp6v1d (Rattus norvegicus) 6480464 2-nitro-4-phenylenediamine results in increased expression of ATP6V1D mRNA CTD PMID:17070881 ATP6V1D Human 2-nitrofluorene increases expression ISO Atp6v1d (Rattus norvegicus) 6480464 2-nitrofluorene results in increased expression of ATP6V1D mRNA CTD PMID:14600272|PMID:22484513|PMID:23052194 ATP6V1D Human 2-nitropropane increases expression ISO Atp6v1d (Rattus norvegicus) 6480464 2-nitropropane results in increased expression of ATP6V1D mRNA CTD PMID:17070881 ATP6V1D Human 3H-1,2-dithiole-3-thione decreases expression ISO Atp6v1d (Rattus norvegicus) 6480464 1,2-dithiol-3-thione results in decreased expression of ATP6V1D mRNA CTD PMID:19162173 ATP6V1D Human 4,4'-diaminodiphenylmethane increases expression ISO Atp6v1d (Rattus norvegicus) 6480464 4,4'-diaminodiphenylmethane results in increased expression of ATP6V1D mRNA CTD PMID:25380136 ATP6V1D Human 4,4'-sulfonyldiphenol decreases expression ISO Atp6v1d (Mus musculus) 6480464 bisphenol S results in decreased expression of ATP6V1D mRNA CTD PMID:39298647 ATP6V1D Human 4,4'-sulfonyldiphenol multiple interactions ISO Atp6v1d (Rattus norvegicus) 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of more ... CTD PMID:36041667 ATP6V1D Human 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one increases expression ISO Atp6v1d (Rattus norvegicus) 6480464 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of ATP6V1D mRNA CTD PMID:14600272|PMID:22484513|PMID:23052194 ATP6V1D Human 4-acetylaminofluorene increases expression ISO Atp6v1d (Rattus norvegicus) 6480464 4-acetylaminofluorene results in increased expression of ATP6V1D mRNA CTD PMID:17070881 ATP6V1D Human 4-nitro-1,2-phenylenediamine increases expression ISO Atp6v1d (Rattus norvegicus) 6480464 1,2-diamino-4-nitrobenzene results in increased expression of ATP6V1D mRNA CTD PMID:17070881 ATP6V1D Human acrolein multiple interactions EXP 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of more ... CTD PMID:32699268 ATP6V1D Human acrylamide increases expression ISO Atp6v1d (Rattus norvegicus) 6480464 Acrylamide results in increased expression of ATP6V1D mRNA CTD PMID:28959563 ATP6V1D Human aflatoxin B1 increases expression ISO Atp6v1d (Rattus norvegicus) 6480464 Aflatoxin B1 results in increased expression of ATP6V1D mRNA CTD PMID:14600272|PMID:22484513|PMID:23052194|PMID:23385219|PMID:23630614|PMID:25378103|PMID:33354967 ATP6V1D Human aflatoxin B1 decreases methylation EXP 6480464 Aflatoxin B1 results in decreased methylation of ATP6V1D gene CTD PMID:27153756 ATP6V1D Human aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of ATP6V1D mRNA CTD PMID:27153756 ATP6V1D Human alpha-pinene multiple interactions EXP 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of more ... CTD PMID:32699268 ATP6V1D Human anthracen-2-amine increases expression ISO Atp6v1d (Rattus norvegicus) 6480464 2-anthramine results in increased expression of ATP6V1D mRNA CTD PMID:23038007 ATP6V1D Human Aroclor 1254 decreases expression ISO Atp6v1d (Mus musculus) 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of ATP6V1D mRNA CTD PMID:23650126 ATP6V1D Human arsenite(3-) multiple interactions EXP 6480464 arsenite promotes the reaction [G3BP1 protein binds to ATP6V1D mRNA] CTD PMID:32406909 ATP6V1D Human benzo[a]pyrene increases expression ISO Atp6v1d (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of ATP6V1D mRNA CTD PMID:21715664 ATP6V1D Human beta-lapachone decreases expression EXP 6480464 beta-lapachone results in decreased expression of ATP6V1D mRNA CTD PMID:38218311 ATP6V1D Human beta-lapachone increases expression EXP 6480464 beta-lapachone results in increased expression of ATP6V1D mRNA CTD PMID:38218311 ATP6V1D Human bisphenol A increases expression ISO Atp6v1d (Rattus norvegicus) 6480464 bisphenol A results in increased expression of ATP6V1D mRNA CTD PMID:25181051|PMID:32145629 ATP6V1D Human bisphenol A multiple interactions ISO Atp6v1d (Rattus norvegicus) 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of more ... CTD PMID:36041667 ATP6V1D Human bisphenol A decreases expression ISO Atp6v1d (Mus musculus) 6480464 bisphenol A results in decreased expression of ATP6V1D mRNA CTD PMID:33221593 ATP6V1D Human bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of ATP6V1D mRNA; bisphenol A results in decreased expression more ... CTD PMID:29275510|PMID:33376534 ATP6V1D Human bisphenol F multiple interactions ISO Atp6v1d (Rattus norvegicus) 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of more ... CTD PMID:36041667 ATP6V1D Human Brodifacoum increases expression ISO Atp6v1d (Rattus norvegicus) 6480464 bromfenacoum results in increased expression of ATP6V1D protein CTD PMID:28903499 ATP6V1D Human cadmium dichloride increases expression ISO Atp6v1d (Mus musculus) 6480464 Cadmium Chloride results in increased expression of ATP6V1D mRNA CTD PMID:30030080 ATP6V1D Human cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of ATP6V1D mRNA CTD PMID:38568856 ATP6V1D Human caffeine decreases phosphorylation EXP 6480464 Caffeine results in decreased phosphorylation of ATP6V1D protein CTD PMID:35688186 ATP6V1D Human captan increases expression ISO Atp6v1d (Mus musculus) 6480464 Captan results in increased expression of ATP6V1D mRNA CTD PMID:31558096 ATP6V1D Human chloropicrin affects expression EXP 6480464 chloropicrin affects the expression of ATP6V1D mRNA CTD PMID:26352163 ATP6V1D Human clofibric acid multiple interactions ISO Atp6v1d (Rattus norvegicus) 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of ATP6V1D mRNA CTD PMID:17602206 ATP6V1D Human cocaine affects expression ISO Atp6v1d (Rattus norvegicus) 6480464 Cocaine affects the expression of ATP6V1D mRNA CTD PMID:20187946 ATP6V1D Human copper(II) sulfate increases expression EXP 6480464 Copper Sulfate results in increased expression of ATP6V1D mRNA CTD PMID:19549813 ATP6V1D Human CU-O LINKAGE increases expression EXP 6480464 cupric oxide results in increased expression of ATP6V1D mRNA CTD PMID:22077320 ATP6V1D Human cyclosporin A increases expression EXP 6480464 Cyclosporine results in increased expression of ATP6V1D mRNA CTD PMID:25562108 ATP6V1D Human deoxynivalenol decreases expression EXP 6480464 deoxynivalenol results in decreased expression of ATP6V1D protein CTD PMID:33890134 ATP6V1D Human dicrotophos decreases expression EXP 6480464 dicrotophos results in decreased expression of ATP6V1D mRNA CTD PMID:28302478 ATP6V1D Human diethylstilbestrol increases expression ISO Atp6v1d (Rattus norvegicus) 6480464 Diethylstilbestrol results in increased expression of ATP6V1D mRNA CTD PMID:37077353 ATP6V1D Human doxorubicin increases expression EXP 6480464 Doxorubicin results in increased expression of ATP6V1D mRNA CTD PMID:29803840 ATP6V1D Human doxorubicin multiple interactions ISO Atp6v1d (Rattus norvegicus) 6480464 dehydroandrographolide inhibits the reaction [Doxorubicin results in decreased expression of ATP6V1D mRNA] CTD PMID:38964637 ATP6V1D Human doxorubicin decreases expression ISO Atp6v1d (Rattus norvegicus) 6480464 Doxorubicin results in decreased expression of ATP6V1D mRNA CTD PMID:38964637 ATP6V1D Human epoxiconazole decreases expression ISO Atp6v1d (Mus musculus) 6480464 epoxiconazole results in decreased expression of ATP6V1D mRNA CTD PMID:35436446 ATP6V1D Human ethanol increases expression ISO Atp6v1d (Mus musculus) 6480464 Ethanol results in increased expression of ATP6V1D mRNA CTD PMID:30319688 ATP6V1D Human ethanol multiple interactions ISO Atp6v1d (Mus musculus) 6480464 Ethanol affects the expression of and affects the splicing of ATP6V1D mRNA CTD PMID:30319688 ATP6V1D Human ethyl methanesulfonate increases expression EXP 6480464 Ethyl Methanesulfonate results in increased expression of ATP6V1D mRNA CTD PMID:23649840 ATP6V1D Human finasteride increases expression ISO Atp6v1d (Rattus norvegicus) 6480464 Finasteride results in increased expression of ATP6V1D mRNA CTD PMID:24136188 ATP6V1D Human flutamide increases expression ISO Atp6v1d (Rattus norvegicus) 6480464 Flutamide results in increased expression of ATP6V1D mRNA CTD PMID:24136188 ATP6V1D Human folic acid multiple interactions ISO Atp6v1d (Mus musculus) 6480464 [1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ATP6V1D mRNA CTD PMID:22206623 ATP6V1D Human folic acid decreases expression ISO Atp6v1d (Mus musculus) 6480464 Folic Acid results in decreased expression of ATP6V1D mRNA CTD PMID:25629700 ATP6V1D Human folpet increases expression ISO Atp6v1d (Mus musculus) 6480464 folpet results in increased expression of ATP6V1D mRNA CTD PMID:31558096 ATP6V1D Human furan increases expression ISO Atp6v1d (Rattus norvegicus) 6480464 furan results in increased expression of ATP6V1D mRNA CTD PMID:26194646 ATP6V1D Human gentamycin increases expression ISO Atp6v1d (Rattus norvegicus) 6480464 Gentamicins results in increased expression of ATP6V1D mRNA CTD PMID:33387578 ATP6V1D Human GSK-J4 increases expression EXP 6480464 GSK-J4 results in increased expression of ATP6V1D mRNA CTD PMID:29301935 ATP6V1D Human Heliotrine increases expression ISO Atp6v1d (Rattus norvegicus) 6480464 heliotrine results in increased expression of ATP6V1D mRNA CTD PMID:32419051 ATP6V1D Human hydrazine increases expression ISO Atp6v1d (Rattus norvegicus) 6480464 hydrazine results in increased expression of ATP6V1D mRNA CTD PMID:15370871 ATP6V1D Human hydrogen peroxide affects expression EXP 6480464 Hydrogen Peroxide affects the expression of ATP6V1D mRNA CTD PMID:20044591 ATP6V1D Human isoniazide increases expression EXP 6480464 Isoniazid results in increased expression of ATP6V1D protein CTD PMID:40015660 ATP6V1D Human isotretinoin decreases expression EXP 6480464 Isotretinoin results in decreased expression of ATP6V1D mRNA CTD PMID:20436886 ATP6V1D Human ivermectin decreases expression EXP 6480464 Ivermectin results in decreased expression of ATP6V1D protein CTD PMID:32959892 ATP6V1D Human ketoconazole increases expression ISO Atp6v1d (Rattus norvegicus) 6480464 Ketoconazole results in increased expression of ATP6V1D mRNA CTD PMID:37077353 ATP6V1D Human methidathion increases expression ISO Atp6v1d (Mus musculus) 6480464 methidathion results in increased expression of ATP6V1D mRNA CTD PMID:34813904 ATP6V1D Human methyl methanesulfonate increases expression EXP 6480464 Methyl Methanesulfonate results in increased expression of ATP6V1D mRNA CTD PMID:23649840 ATP6V1D Human N-nitrosodiethylamine multiple interactions ISO Atp6v1d (Rattus norvegicus) 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of ATP6V1D mRNA CTD PMID:17602206 ATP6V1D Human N-nitrosodimethylamine increases expression ISO Atp6v1d (Rattus norvegicus) 6480464 Dimethylnitrosamine results in increased expression of ATP6V1D mRNA CTD PMID:14600272|PMID:25380136 ATP6V1D Human N-nitrosomorpholine increases expression ISO Atp6v1d (Rattus norvegicus) 6480464 N-nitrosomorpholine results in increased expression of ATP6V1D mRNA CTD PMID:19716841 ATP6V1D Human nefazodone increases expression ISO Atp6v1d (Rattus norvegicus) 6480464 nefazodone results in increased expression of ATP6V1D mRNA CTD PMID:24136188 ATP6V1D Human okadaic acid decreases expression EXP 6480464 Okadaic Acid results in decreased expression of ATP6V1D protein CTD PMID:38832940 ATP6V1D Human okadaic acid increases expression EXP 6480464 Okadaic Acid results in increased expression of ATP6V1D mRNA CTD PMID:38832940 ATP6V1D Human osimertinib increases expression ISO Atp6v1d (Rattus norvegicus) 6480464 osimertinib results in increased expression of ATP6V1D mRNA CTD PMID:38734218 ATP6V1D Human ozone multiple interactions EXP 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of more ... CTD PMID:32699268 ATP6V1D Human paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of ATP6V1D mRNA CTD PMID:22230336 ATP6V1D Human paracetamol increases expression ISO Atp6v1d (Rattus norvegicus) 6480464 Acetaminophen results in increased expression of ATP6V1D mRNA CTD PMID:33387578 ATP6V1D Human perfluorooctanoic acid increases expression ISO Atp6v1d (Rattus norvegicus) 6480464 perfluorooctanoic acid results in increased expression of ATP6V1D mRNA CTD PMID:19162173 ATP6V1D Human picoxystrobin increases expression EXP 6480464 picoxystrobin results in increased expression of ATP6V1D mRNA CTD PMID:33512557 ATP6V1D Human pirinixic acid increases expression ISO Atp6v1d (Rattus norvegicus) 6480464 pirinixic acid results in increased expression of ATP6V1D mRNA CTD PMID:19162173 ATP6V1D Human piroxicam decreases expression EXP 6480464 Piroxicam results in decreased expression of ATP6V1D mRNA CTD PMID:21858171 ATP6V1D Human pregnenolone 16alpha-carbonitrile increases expression ISO Atp6v1d (Rattus norvegicus) 6480464 Pregnenolone Carbonitrile results in increased expression of ATP6V1D mRNA CTD PMID:19162173 ATP6V1D Human rac-lactic acid decreases expression EXP 6480464 Lactic Acid results in decreased expression of ATP6V1D mRNA CTD PMID:30851411 ATP6V1D Human resveratrol multiple interactions EXP 6480464 [Plant Extracts co-treated with Resveratrol] results in increased expression of ATP6V1D mRNA CTD PMID:23557933 ATP6V1D Human rotenone increases expression EXP 6480464 Rotenone results in increased expression of ATP6V1D mRNA CTD PMID:31648047 ATP6V1D Human silicon dioxide increases expression ISO Atp6v1d (Mus musculus) 6480464 Silicon Dioxide results in increased expression of ATP6V1D mRNA CTD PMID:29203145 ATP6V1D Human sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of ATP6V1D mRNA CTD PMID:38568856 ATP6V1D Human sodium dichromate increases expression ISO Atp6v1d (Rattus norvegicus) 6480464 sodium bichromate results in increased expression of ATP6V1D mRNA CTD PMID:25993096 ATP6V1D Human sodium dichromate increases expression ISO Atp6v1d (Mus musculus) 6480464 sodium bichromate results in increased expression of ATP6V1D mRNA CTD PMID:31558096 ATP6V1D Human Soman decreases expression ISO Atp6v1d (Rattus norvegicus) 6480464 Soman results in decreased expression of ATP6V1D mRNA CTD PMID:19281266 ATP6V1D Human tamoxifen affects expression ISO Atp6v1d (Mus musculus) 6480464 Tamoxifen affects the expression of ATP6V1D mRNA CTD PMID:17555576 ATP6V1D Human temozolomide decreases expression EXP 6480464 Temozolomide results in decreased expression of ATP6V1D mRNA CTD PMID:31758290 ATP6V1D Human thimerosal increases expression EXP 6480464 Thimerosal results in increased expression of ATP6V1D mRNA CTD PMID:27188386 ATP6V1D Human thioacetamide increases expression ISO Atp6v1d (Rattus norvegicus) 6480464 Thioacetamide results in increased expression of ATP6V1D mRNA CTD PMID:23411599|PMID:34492290 ATP6V1D Human thiram increases expression EXP 6480464 Thiram results in increased expression of ATP6V1D mRNA CTD PMID:38568856 ATP6V1D Human titanium dioxide decreases methylation ISO Atp6v1d (Mus musculus) 6480464 titanium dioxide results in decreased methylation of ATP6V1D gene CTD PMID:35295148 ATP6V1D Human trichloroethene increases expression ISO Atp6v1d (Rattus norvegicus) 6480464 Trichloroethylene results in increased expression of ATP6V1D mRNA CTD PMID:33387578 ATP6V1D Human trichostatin A affects expression EXP 6480464 trichostatin A affects the expression of ATP6V1D mRNA CTD PMID:28542535 ATP6V1D Human triphenyl phosphate affects expression EXP 6480464 triphenyl phosphate affects the expression of ATP6V1D mRNA CTD PMID:37042841 ATP6V1D Human tunicamycin decreases expression EXP 6480464 Tunicamycin results in decreased expression of ATP6V1D mRNA CTD PMID:29453283 ATP6V1D Human urethane increases expression EXP 6480464 Urethane results in increased expression of ATP6V1D mRNA CTD PMID:28818685 ATP6V1D Human valproic acid increases expression ISO Atp6v1d (Mus musculus) 6480464 Valproic Acid results in increased expression of ATP6V1D mRNA CTD PMID:20546886 ATP6V1D Human valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of ATP6V1D mRNA CTD PMID:23179753|PMID:29154799 ATP6V1D Human valproic acid affects expression EXP 6480464 Valproic Acid affects the expression of ATP6V1D mRNA CTD PMID:25979313 ATP6V1D Human vorinostat increases expression EXP 6480464 vorinostat results in increased expression of ATP6V1D mRNA CTD PMID:27188386